Diabetes: Page 9

  • Tandem Diabetes Control-IQ
    Image attribution tooltip
    Courtesy of Tandem Diabetes
    Image attribution tooltip

    Tandem sees growth in new product launches after $95M loss on decline in pump placements

    Craig Hallum analysts said 2022 was a “tough year” for Tandem but noted the company’s 2023 forecast should “properly” set expectations.

    By • Feb. 23, 2023
  • Three watches stand on display with digital screens.
    Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    Apple makes strides in watch-based blood glucose tracking, Bloomberg reports

    The company has been working on needle-free blood glucose tracking technology for 12 years, but has yet to show any meaningful clinical data, a J.P. Morgan analyst wrote.

    By • Feb. 22, 2023
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip

    Embecta raises 2023 earnings forecast after better-than-expected start

    Almost a year after the company spun off from Becton Dickinson, CEO Dev Kurdikar said Embecta’s quarterly results “exceeded our initial expectations” in a challenging market.

    By • Feb. 15, 2023
  • A phone-like device shows a bolus insulin measurement, with a white, U-shaped device to the right.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet pays Bigfoot Biomedical $25M for pump-based automated insulin delivery technology

    Insulet framed the Bigfoot deal as a way to double its IP portfolio and strengthen its position in the insulin pump market.

    By • Feb. 14, 2023
  • Nick Jonas poses in front of a glowing background, wearing a small, round device on his upper arm
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom secures Medicare coverage for G7 CGM with device set to launch this week

    The decision by the CMS will include coverage for people with Type 1 and Type 2 diabetes who are on intensive insulin therapy.

    By • Feb. 13, 2023
  • Nick Jonas, Dexcom
    Image attribution tooltip
    Courtesy of Dexcom, Nick Jonas Super Bowl kit
    Image attribution tooltip

    Dexcom reports another record year of new customers amid continued demand for G6 device

    The diabetes tech firm aims to keep boosting awareness of its CGMs with another Super Bowl commercial.

    By • Feb. 9, 2023
  • A rounded, metal device says "Abbott Proclaim XR" on the front
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott device approval sets up battle with Medtronic, Nevro for diabetic peripheral neuropathy treatment

    Three firms are bringing their devices to a $3 billion to $5 billion market, aiming to relieve a painful side effect of diabetes.

    By • Feb. 6, 2023
  • Wall Street sign in the financial district of New York City.
    Image attribution tooltip
    JaysonPhotography via Getty Images
    Image attribution tooltip

    Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023

    Still, the latest round of quarterly results show that hospital staffing and supply chain remain a challenge.

    By • Feb. 6, 2023
  • Professional photo of Elizabeth Gasser
    Image attribution tooltip
    Permission granted by Tandem Diabetes Care
    Image attribution tooltip
    Q&A

    Friday Q&A: Tandem’s chief strategy officer talks tubeless pumps, Type 2 plans

    Elizabeth Gasser also discusses the company’s recent acquisition of AMF Medical as well as how it factors environmental impact into device design.

    By • Jan. 27, 2023
  • Abbott company sign outside
    Image attribution tooltip

    Courtesy of Abbott Laboratories

    Image attribution tooltip

    Abbott sees ‘signs of stability’ for 2023 as hospital staffing, supply chain improves

    While the company continues to grapple with supply shortages and procedure restrictions, it sold more COVID-19 tests than expected in the fourth quarter.

    By • Jan. 25, 2023
  • A phone-like device shows a bolus insulin measurement, with a white, U-shaped device to the right.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet reports personal-data leak of 29,000 insulin pump customers

    In a recall communication to users, Insulet shared information with its website performance and marketing partners through cookies and other trackers embedded in its website. 

    By • Jan. 24, 2023
  • A glucometer, insulet pen and syringes on a blue background
    Image attribution tooltip
    Volodymyr Bushmelov via Getty Images
    Image attribution tooltip
    Deep Dive // Medtech trends in 2023

    Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023

    From new product launches to regulatory changes that could expand CGM coverage, company executives and analysts share their predictions.

    By • Jan. 20, 2023
  • Professional photo of Kevin Sayer
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip
    Q&A

    Dexcom CEO discusses 2023 plans, expanding to more patients with Type 2 diabetes

    MedTech Dive caught up with Kevin Sayer for a conversation about forthcoming product launches and long-term plans to expand CGMs to a broader group of patients. 

    By • Updated Jan. 20, 2023
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    How Abbott plans to make its Freestyle Libre a $10B product

    CEO Robert Ford discussed plans to grow the market for Abbott’s continuous glucose monitors, and its broader diabetes strategy.

    By • Jan. 10, 2023
  • A portrait of Steven Russell, MD
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Beta Bionics hires Harvard diabetes expert as CMO ahead of artificial pancreas launch

    Steven Russell has joined the company as chief medical officer, completing a new leadership team that began taking shape with the appointment of Sean Saint as CEO last year.

    By • Jan. 10, 2023
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom forecasts 2023 revenue to rise as much as 20% on G7 launch

    Sales are expected to reach $3.35 billion to $3.49 billion for the full year.

    By • Jan. 9, 2023
  • Medtronic's MiniMed 780G Advanced Hybrid Closed Loop System
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    ‘Mea culpa’: What Goldman Sachs analysts got wrong about Medtronic in 2022

    Medtronic has struggled to deliver on key projects in recent years, leading to a decline in its stock performance.

    By • Jan. 4, 2023
  • Medicine for diabetes disease of health care and self-care concept. Plus size African American woman with syringe making insulin injections at abdominal skin (intra subcutaneous) for hyperglycemia by
    Image attribution tooltip
    Pixelseffect via Getty Images
    Image attribution tooltip

    As diabetes technology advances, blood glucose control declines: study

    Mexican-American and non-Hispanic Black adults saw the greatest drop as the proportion of patients with glycemic control fell from 29.2% between 1988 and 1994 to 27.5% between 2013 and 2020.

    By • Dec. 21, 2022
  • Concept image of insulin aspart with fake labeling
    Image attribution tooltip
    Samara Heisz via Getty Images
    Image attribution tooltip

    Novo Nordisk expands Amalgam Rx insulin app pact, plots integration with other devices

    Supported by Novo Nordisk, Amalgam Rx will incorporate and integrate with connected insulin delivery devices, continuous glucose monitors and electronic health records.

    By • Dec. 20, 2022
  • The Dexcom G7 Continuous Glucose Monitor
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom’s Jake Leach discusses preparations for G7 launch next year

    The diabetes tech company is in conversations with payers and is opening a new manufacturing plant ahead of the planned launch of its newest CGM, the COO said. 

    By • Dec. 15, 2022
  • Tandem Diabetes Control-IQ
    Image attribution tooltip
    Courtesy of Tandem Diabetes
    Image attribution tooltip

    Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market

    The deal will give Tandem control of Sigi, a reusable, rechargeable patch pump that is designed to be smaller and lighter than existing devices.

    By • Dec. 14, 2022
  • Ypsomed's YpsoPump for diabetes management
    Image attribution tooltip
    Courtesy of Ypsomed
    Image attribution tooltip

    Ypsomed seeks new partner for US insulin pump launch as Lilly quits deal

    The companies planned to launch a customized version of the YpsoPump that used pre-filled insulin cartridges for Lilly’s rapid-acting insulins.

    By • Dec. 12, 2022
  • The Dexcom G7 Continuous Glucose Monitor
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom’s G7 glucose monitor wins awaited FDA clearance

    The new Dexcom monitor is expected to generate significant patient demand, as it has been cleared by the FDA for patients with Type 1 and Type 2 diabetes, as well as gestational diabetes.

    By • Dec. 8, 2022
  • A visiting nurse helps a patient at home with CGM monitoring
    Image attribution tooltip
    Phynart Studio/Getty via Getty Images
    Image attribution tooltip

    AI detects prediabetes in CGM data, opening up new use for device: study

    By correctly identifying many patients with prediabetes or Type 2 diabetes, researchers say CGMs can be used to prevent the disease. 

    By • Dec. 6, 2022
  • Team of surgeons operating on patient in hospital - stock photo Four doctors in hospital operating room with patient lying on operating table. Surgical lights shining on medical team performing operat
    Image attribution tooltip
    Johnny Greig via Getty Images
    Image attribution tooltip

    The 10 biggest medtech stories of 2022

    MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.

    By MedTech Dive staff • Dec. 3, 2022